Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | EVP, General Counsel | March 10, 2025 | March 13, 2025 |
| Bausch Health Companies Inc.BHC · Entity 4363 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date March 10, 2025 · Filed March 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 364,296.333 |
Ending reported balance
After 2025-03-10 transaction · row 12
12 source rows · reconciled sequenceRow 1 · 2025-03-10 · Exercise / conversion · Acquired 5,858 · Balance 353,243.333 F1: Represents vesting of one-quarter of market share units granted on March 10, 2021. Row 2 · 2025-03-10 · Other · Disposed 404 · Balance 352,839.333 F2: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Row 3 · 2025-03-10 · Tax withholding · Disposed 2,790 · Balance 350,049.333 F3: Shares withheld for payment of taxes upon vesting of awards. Row 4 · 2025-03-10 · Exercise / conversion · Acquired 5,349 · Balance 355,398.333 F4: Represents vesting of one-quarter of market share units granted on March 10, 2022. Row 5 · 2025-03-10 · Other · Disposed 933 · Balance 354,465.333 F2: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Row 6 · 2025-03-10 · Tax withholding · Disposed 2,259 · Balance 352,206.333 F3: Shares withheld for payment of taxes upon vesting of awards. Row 7 · 2025-03-10 · Exercise / conversion · Acquired 5,415 · Balance 357,621.333 F5: Represents vesting of one-quarter of market share units granted on March 10, 2023. Row 8 · 2025-03-10 · Other · Disposed 923 · Balance 356,698.333 F2: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Row 9 · 2025-03-10 · Tax withholding · Disposed 2,298 · Balance 354,400.333 F3: Shares withheld for payment of taxes upon vesting of awards. Row 10 · 2025-03-10 · Exercise / conversion · Acquired 32,096 · Balance 386,496.333 F6: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Row 11 · 2025-03-10 · Other · Disposed 11,837 · Balance 374,659.333 F7: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Row 12 · 2025-03-10 · Tax withholding · Disposed 10,363 · Balance 364,296.333 F3: Shares withheld for payment of taxes upon vesting of awards. |
| Market Share UnitsSEC Table II · derivative / convertible security · Expires 2025-03-10 | Direct | 0 |
Reported balance
After 2025-03-10 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-03-10 · Exercise / conversion · Disposed 5,858 · Balance 0 F10: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1: Represents vesting of one-quarter of market share units granted on March 10, 2021. |
| Market Share UnitsSEC Table II · derivative / convertible security · Expires 2026-03-10 | Direct | 5,351 |
Reported balance
After 2025-03-10 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2025-03-10 · Exercise / conversion · Disposed 5,349 · Balance 5,351 F11: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4: Represents vesting of one-quarter of market share units granted on March 10, 2022. |
| Market Share UnitsSEC Table II · derivative / convertible security · Expires 2027-03-10 | Direct | 10,833 |
Reported balance
After 2025-03-10 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2025-03-10 · Exercise / conversion · Disposed 5,415 · Balance 10,833 F11: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F5: Represents vesting of one-quarter of market share units granted on March 10, 2023. |
| Market Share UnitsSEC Table II · derivative / convertible security · Expires 2028-03-10 | Direct | 24,770 |
Reported balance
After 2025-03-10 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2025-03-10 · Grant · Acquired 24,770 · Balance 24,770 F12: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F13: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. |
| Performance SharesSEC Table II · derivative / convertible security · Expires 2025-03-10 | Direct | 0 |
Reported balance
After 2025-03-10 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2025-03-10 · Exercise / conversion · Disposed 32,096 · Balance 0 F14: Each performance share converted into one share of common stock upon distribution in the first quarter of 2025 in accordance with the terms of the award and certification of performance results by the Board. F6: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. |
| Performance SharesSEC Table II · derivative / convertible security · Expires 2028-03-10 | Direct | 37,155 |
Reported balance
After 2025-03-10 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2025-03-10 · Grant · Acquired 37,155 · Balance 37,155 F15: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. |
| Common Stock, $0.10 par valueSEC Table I · non-derivative | IndirectBMS Savings and Investment Program | 7,641.38 |
Reported balance
Holding disclosure · report date 2025-03-10 · row 13
Holding and transaction disclosures are not merged.
1 source rowRow 13 · Balance 7,641.38 F8: Based on recent 401(k) plan statement. |
| Common Stock, $0.10 par valueSEC Table I · non-derivative | IndirectTrust (SLAT) | 93,436 |
Reported balance
Holding disclosure · report date 2025-03-10 · row 14
Holding and transaction disclosures are not merged.
1 source rowRow 14 · Balance 93,436 F9: Shares held in a Spousal Lifetime Access Trust (SLAT). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents vesting of one-quarter of market share units granted on March 10, 2021.
F2: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.
F3: Shares withheld for payment of taxes upon vesting of awards.
F4: Represents vesting of one-quarter of market share units granted on March 10, 2022.
F5: Represents vesting of one-quarter of market share units granted on March 10, 2023.
F6: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award.
F7: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board.
F8: Based on recent 401(k) plan statement.
F9: Shares held in a Spousal Lifetime Access Trust (SLAT).
F10: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
F11: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.
F12: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout.
F13: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board.
F14: Each performance share converted into one share of common stock upon distribution in the first quarter of 2025 in accordance with the terms of the award and certification of performance results by the Board.
F15: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board.
Bausch Health Companies Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 102,859 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 5,789 · Balance 102,859 F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:27 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 5,789 | $5.83 | $33,749.87 |
DisclosureSEC source: 0000885590-26-000113 · form4.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,859 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:10 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 6,845 | $4.93 | $33,745.85 |
DisclosureSEC source: 0000885590-26-000091 · form4.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,070 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| May 22, 2026 Filed May 26, 2026 22:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 45,871 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000079 · form4.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,225 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 22:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 5,946 | $5.40 | $32,108.40 |
DisclosureSEC source: 0000885590-26-000047 · form4.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,354 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 21:07 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 4,586 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000002 · form4.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,408 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:14 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 3,673 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-25-000038 · form4.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,822 F1 · shares: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer. Read SEC document |
| July 25, 2025 Filed Jul 29, 2025 20:57 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 30,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-019735 · form4.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,149 F1 · shares: Represents Restricted Share Units ("RSUs"), each representing a contingent right to receive one Common Share, no par value, of Bausch Health Companies Inc., which will vest immediately before the 2026 Annual Meeting of Shareholders. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 37,155 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 20 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,155 Underlying: Common Stock, $0.10 par value · 37,155 shares Expires 2028-03-10 F15 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. F15 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2028, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 32,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 19 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 32,096 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: Each performance share converted into one share of common stock upon distribution in the first quarter of 2025 in accordance with the terms of the award and certification of performance results by the Board. F6 · derivative.exercise_date: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 24,770 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 18 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,770 Underlying: Common Stock, $0.10 par value · 24,770 shares Expires 2028-03-10 F12 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. F13 · derivative.exercise_date: These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 5,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 17 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,833 Underlying: Common Stock, $0.10 par value · 5,415 shares Expires 2027-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F5 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 5,349 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 16 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,351 Underlying: Common Stock, $0.10 par value · 5,349 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 5,858 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · derivative · entry 15 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 5,858 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 10,363 | $63.11 | $654,008.93 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 12 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,296.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 11,837 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 11 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,659.333 F7 · shares: Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 32,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 10 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,496.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Amount represents distribution of performance shares earned under the 2022-2024 Long-Term Performance Award. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,298 | $63.11 | $145,026.78 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 9 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,400.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 923 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 8 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,698.333 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 5,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 7 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,621.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2023. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,259 | $63.11 | $142,565.49 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 6 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,206.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 933 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 5 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,465.333 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 5,349 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 4 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,398.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,790 | $63.11 | $176,076.90 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 3 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,049.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 404 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 2 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,839.333 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2025 Filed Mar 13, 2025 01:32 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 5,858 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000066 · wk-form4_1741829536.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,243.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 42,957 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · derivative · entry 18 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,957 Underlying: Common Stock, $0.10 par value · 42,957 shares Expires 2027-03-10 F15 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027. F15 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 35,139 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · derivative · entry 17 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 35,139 shares Expires 2024-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return. F14 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 28,638 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · derivative · entry 16 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,638 Underlying: Common Stock, $0.10 par value · 28,638 shares Expires 2028-03-10 F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F12 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherMarket Share Units · Derivative | 5,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · derivative · entry 15 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,248 Underlying: Common Stock, $0.10 par value · 5,415 shares Expires 2027-03-10 F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F13 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2023 due to the 80% minimum payout factor not being achieved. F12 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherMarket Share Units · Derivative | 5,349 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · derivative · entry 14 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,700 Underlying: Common Stock, $0.10 par value · 5,349 shares Expires 2026-03-10 F10 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F11 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2022 due to the 80% minimum payout factor not being achieved. F12 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 5,856 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · derivative · entry 13 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,858 Underlying: Common Stock, $0.10 par value · 5,856 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 5,789 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · derivative · entry 12 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 5,789 shares Expires 2024-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 11,695 | $53.79 | $629,074.05 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · nonDerivative · entry 9 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,385.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 12,232 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · nonDerivative · entry 8 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 359,080.333 F6 · shares: Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 35,139 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · nonDerivative · entry 7 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,312.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Amount represents distribution of performance shares earned under the 2021-2023 Long-Term Performance Award. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,475 | $53.79 | $133,130.25 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · nonDerivative · entry 6 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,173.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 1,009 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · nonDerivative · entry 5 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,648.333 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 5,856 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · nonDerivative · entry 4 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,657.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 2,490 | $53.79 | $133,937.10 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · nonDerivative · entry 3 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,801.333 F3 · shares: Shares withheld for payment of taxes upon vesting of awards. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 912 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · nonDerivative · entry 2 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,291.333 F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 5,789 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-24-000076 · wk-form4_1710294212.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 337,203.333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 19:38 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 9,830 | $48.75 | $479,163.35 |
DisclosureSEC source: 0000014272-23-000187 · wk-form4_1700854689.xml · nonDerivative · entry 2 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Indirect · Trust (SLAT) Disclosed balance after: 93,436 F1 · shares: On November 21, 2023, the reporting person transferred 9,830 shares of Common Stock to a Spousal Lifetime Access Trust (SLAT). In exchange for the shares, the SLAT transferred cash to the reporting person in the amount of $479,163.35 based on the average high/low price of the shares which was $48.745 per share. The deposit of shares into the SLAT resulted in an increase in the number of shares the reporting person beneficially owns indirectly through such SLAT and a corresponding decrease in the number of shares the reporting person owns directly. F2 · price: The price reported reflects the average of the high/low market prices of $49.04 and $48.45 on the date of the transfer. Read SEC document |
| November 21, 2023 Filed Nov 24, 2023 19:38 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 9,830 | $48.75 | $479,163.35 |
DisclosureSEC source: 0000014272-23-000187 · wk-form4_1700854689.xml · nonDerivative · entry 1 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,414.333 F1 · shares: On November 21, 2023, the reporting person transferred 9,830 shares of Common Stock to a Spousal Lifetime Access Trust (SLAT). In exchange for the shares, the SLAT transferred cash to the reporting person in the amount of $479,163.35 based on the average high/low price of the shares which was $48.745 per share. The deposit of shares into the SLAT resulted in an increase in the number of shares the reporting person beneficially owns indirectly through such SLAT and a corresponding decrease in the number of shares the reporting person owns directly. F2 · price: The price reported reflects the average of the high/low market prices of $49.04 and $48.45 on the date of the transfer. Read SEC document |
| March 10, 2023 Filed Mar 15, 2023 00:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 32,494 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-23-000066 · wf-form4_167884011829189.xml · derivative · entry 24 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,494 Underlying: Common Stock, $0.10 par value · 32,494 shares Expires 2026-03-10 F15 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026. F15 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026. Read SEC document |
| March 10, 2023 Filed Mar 15, 2023 00:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 34,726 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-23-000066 · wf-form4_167884011829189.xml · derivative · entry 23 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 34,726 shares Expires 2023-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2023, subject to a Total Shareholder Return. F14 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2023, subject to a Total Shareholder Return. Read SEC document |
| March 10, 2023 Filed Mar 15, 2023 00:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 21,663 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-23-000066 · wf-form4_167884011829189.xml · derivative · entry 22 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,663 Underlying: Common Stock, $0.10 par value · 21,663 shares Expires 2027-03-10 F12 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F13 · derivative.exercise_date: Twenty-five percent of these market share units will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2023 Filed Mar 15, 2023 00:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 5,349 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-23-000066 · wf-form4_167884011829189.xml · derivative · entry 21 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,049 Underlying: Common Stock, $0.10 par value · 5,349 shares Expires 2026-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. F6 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2022. Read SEC document |
| March 10, 2023 Filed Mar 15, 2023 00:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 5,856 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-23-000066 · wf-form4_167884011829189.xml · derivative · entry 20 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,714 Underlying: Common Stock, $0.10 par value · 5,856 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F5 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2023 Filed Mar 15, 2023 00:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 5,787 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-23-000066 · wf-form4_167884011829189.xml · derivative · entry 19 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,789 Underlying: Common Stock, $0.10 par value · 5,787 shares Expires 2024-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
| March 10, 2023 Filed Mar 15, 2023 00:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 6,272 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-23-000066 · wf-form4_167884011829189.xml · derivative · entry 18 LEUNG SANDRA · CIK 0001199294 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 6,272 shares Expires 2023-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.